glp-1 news november 2025 Harvard Medical School Researcher Wins Breakthrough Prize for Work on GLP-1 Market Trends and Global
Description
Instead, it focuses on daily habits, nutrition targets, behavior change and long-term sustainability
Its not FDA-approved for obesity
But heres the good news: Youre not alone, and youre not expected to figure it out by yourself
T2DM is characterized by the presence of chronic fluctuating hyperglycemia, obesity-associated insulin resistance as well as the impaired secretion of insulin and dysfunction of the incretin system
